Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease;Calprotectina fecal como marcador diferencial entre patología gastrointestinal orgánica y funcional

Revista Espanola de Enfermedades Digestivas

Volumn 99, Issue 12, 2007, Pages 689-693

  Bonnín Tomàs, Anna ^a,b   Vila Vidal, M ^a   Rosell Camps, A ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b NONE   (Spain)

Author keywords

Fecal calprotectin; Functional gastrointestinal diseases; Inflammatory bowel disease; Pediatry

Indexed keywords

CALGRANULIN;

ARTICLE; CLINICAL ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENTERITIS; ENZYME IMMUNOASSAY; FECES ANALYSIS; GASTROINTESTINAL SYMPTOM; HUMAN; PATHOGENESIS; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FECES; GASTROINTESTINAL DISEASES; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; RETROSPECTIVE STUDIES;

EID: 40949119423     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterol 2002; 123 (2): 450-60.
2. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP. New insights into the biology of the acute phase response. J Clin Immunol 1999;19 (4): 203-14.
3. Tibble JA, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 2001; 7 (4): 460-5.
4. Fagerhol MK. Calprotectin, a faecal marker of organic gastrointestinal abnormality. Lancet 2000; 356 (9244): 1783-4.
5. Carroccio A, Iacono G, Cottone M, Di PL, Cartabellotta F, Cavataio F, et al. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: A prospective study in adults and children. Clin Chem 2003;49 (6 Pt 1): 861-7.
6. Canani RB, de Horatio LT, Terrin G, Romano MT, Miele E, Staiano A, et al. Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2006; 42 (1): 9-15.
7. Díaz Martín JJ, Codoceo Alquinta R, Sarriá Osés J, Molina Arias M, Prieto Bozano G, Polanco Allué I. Estudio de la utilidad de calprotectina fecal como marcador de inflamación en pacientes pediátricos con enfermedad inflamatoria intestinal. An Esp Pediatr 2002; 56 (Supl. 3): 25-6.
8. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27 (9): 793-8.
9. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999; 34 (1): 50-4.
10. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterol 2000; 119 (1): 15-22.
11. Pardi DS, Sandborn WJ. Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers? Gut 2005; 54 (3): 321-2.
12. Armas HM et al. Calprotectina fecal en el diagnóstico de la enfermedad inflamatoria intestinal. Comunicación Congreso. An Pediatr (Barc) 2005; 62 (Supl. 2): 236.
13. Dale I, Brandtzaeg P, Fagerhol MK, Scott H. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol 1985; 84 (1): 24-34.
14. Summerton CB, Longlands MG, Wiener K, Shreeve DR. Faecal calprotectin: A marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002; 14 (8): 841-5.
15. Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997; 50 (3): 113-23.
16. Hanai H, Takeuchi K, Iida T, Kashiwagi N, Saniabadi AR, Matsushita I, et al. Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis. Dig Dis Sci 2004; 49 (9): 1438-43.
17. Fagerhol MK. Nomenclature for proteins: Is calprotectin a proper name for the elusive myelomonocytic protein? Clin Mol Pathol 1996; 49 (2): M74-M79.
18. Ton H, Brandsnes, Dale S, Holtlund J, Skuibina E, Schjonsby H, et al. Improved assay for fecal calprotectin. Clin Chim Acta 2000; 292 (1-2): 41-54.
19. Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ, et al. Childhood functional gastrointestinal disorders. Gut 1999; 45 (Supl. 2): II60-II68.
20. Gómez BJ, Ortiz C, Romero R, et al. Diagnostic yield of 335 push video-enteroscopies. Rev Esp Enferm Dig 2006; 98 (2): 82-92.
21. Bremner A, Roked S, Robinson R, Phillips I, Beattie M. Faecal calprotectin in children with chronic gastrointestinal symptoms. Acta Paediatr 2005; 94 (12): 1855-8.
22. Fagerberg UL, Loof L, Myrdal U, Hansson LO, Finkel Y. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 2005; 40 (4): 450-5.
23. García Sánchez MV, González R, Iglesias FE, Gómez CF, Casais JL, Cerezo RA, et al. Diagnostic value of fecal calprotectin in predicting an abnormal colonoscopy. Med Clin (Barc) 2006; 127 (2): 41-6.
24. Fagerberg UL, Loof L, Merzoug RD, Hansson LO, Finkel Y. Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr 2003; 37 (4): 468-72.
25. Olafsdottir E, Aksnes L, Fluge G, Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002; 91 (1): 45-50.
26. Campeotto F, Butel MJ, Kalach N, Derrieux S, Ubert-Jacquin C, Barbot L, et al. High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed 2004; 89 (4): F353-F355.
27. Verdú Rico J, Juste M, Jover R, Muñoz Acosta J, Muñoz J, Martínez A, et al. La gammagrafía con leucocitis marcados con 99mTc-HM-PAO en el diagnóstico y seguimiento de la enfermedad inflamatoria intestinal. An Pediatr (Barc) 2006; 64 (5): 457-63.
28. van der Sluijs Veer G, van der Horen B, Russel MG, van den Bergh FA. Time-resolved fluorimetric immunoassay of calprotectin: Technical and clinical aspects in diagnosis of inflammatory bowel diseases. Clin Chem Lab Med 2006; 44 (3): 292-8.